Publication | Closed Access

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Surgical OncologyRadiation TherapyMedicineProstatic DiseaseOncologyRadiation OncologyTreatment VerificationUltra-hypofractionated VersusPhase 3RadiologyHealth Sciences